Inovio Pharmaceuticals
American biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Inovio Pharmaceuticals?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).[4][5]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Nasdaq: INO | |
Industry | Biotechnology |
Founded | 1999 |
Headquarters | Plymouth Meeting, Pennsylvania |
Key people | Jacqueline Shea, Ph.D. (President and CEO) |
Products | DNA-based Medicines and Vaccines[1] |
Revenue | $7 Million(2020)[2] |
Number of employees | 262 [3] |
Website | inovio.com |
Close